Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Braz. j. med. biol. res ; 43(2): 195-200, Feb. 2010. graf
Article in English | LILACS | ID: lil-538230

ABSTRACT

Variations in the estrogenic activity of the phytoestrogen-rich plant, Pueraria mirifica, were determined with yeast estrogen screen (YES) consisting of human estrogen receptors (hER) hERá and hERâ and human transcriptional intermediary factor 2 (hTIF2) or human steroid receptor coactivator 1 (hSRC1), respectively, together with the â-galactosidase expression cassette. Relative estrogenic potency was expressed by determining the â-galactosidase activity (EC50) of the tuber extracts in relation to 17â-estradiol. Twenty-four and 22 of the plant tuber ethanolic extracts interacted with hERá and hERâ, respectively, with a higher relative estrogenic potency with hERâ than with hERá. Antiestrogenic activity of the plant extracts was also determined by incubation of plant extracts with 17â-estradiol prior to YES assay. The plant extracts tested exhibited antiestrogenic activity. Both the estrogenic and the antiestrogenic activity of the tuber extracts were metabolically activated with the rat liver S9-fraction prior to the assay indicating the positive influence of liver enzymes. Correlation analysis between estrogenic potency and the five major isoflavonoid contents within the previously HPLC-analyzed tuberous samples namely puerarin, daidzin, genistin, daidzein, and genistein revealed a negative result.


Subject(s)
Animals , Rats , Estrogen Receptor alpha/analysis , Estrogen Receptor beta/analysis , Liver/drug effects , Plant Extracts/pharmacology , Pueraria/chemistry , Biological Assay , Chromatography, High Pressure Liquid , Estradiol/metabolism , Estrogen Receptor alpha/metabolism , Estrogen Receptor beta/metabolism , Isoflavones/analysis , Isoflavones/metabolism , Liver/metabolism , Nuclear Receptor Coactivator 1/metabolism , /metabolism , beta-Galactosidase/analysis , beta-Galactosidase/antagonists & inhibitors
2.
Pakistan Journal of Pharmaceutical Sciences. 2010; 23 (2): 236-240
in English | IMEMR | ID: emr-98361

ABSTRACT

In this era, major community worldwide is suffering from diabetes type II, cancer and neurodegenerative disorders. To overcome these diseases, in the screening of Korean medicinal plants, we studied the whole plant of Boehmeria nivea [B. nivea]. The methanolic leaf, stem and root extracts of B. nivea and their respective n-hexane, methylene chloride [CH[2]C1[2]], ethyl acetate [EtOAc], n-butanol [BuOH] and aqueous fractions were investigated for their total phenolic content [TPC], l,l-diphenyl-2-picrylhydrazyl [DPPH] free radical scavenging activity, a-glucosidase, p-glucosidase, a-galactosidase, P-galactosidase, acetylcholinesterase [AChE] and butyrylcholinesterase [BChE] enzyme inhibition activities. Profound TPC and DPPH free radical scavenging activities were observed in the EtOAc and BuOH fractions of root, where the BuOH fraction showed high-pitched a-glucosidase inhibition and the EtOAc layer showed the maximum p-glucosidase inhibition. Furthermore, the leaf extract demonstrated the highest P-galactosidase inhibitory activity, but no a-galactosidase inhibition was seen in any of the plant parts. Notable BChE and moderate AChE inhibitory activity was found in whole plant. It can be suggested that whole plant of B. nivea provides a strong biochemical rationale as one of the good choices for the treatment of diabetes type II, cancer and neurodegenerative diseases [AD, etc]


Subject(s)
Cholinesterase Inhibitors/pharmacology , Enzyme Inhibitors/pharmacology , Plant Extracts/pharmacology , alpha-Galactosidase/antagonists & inhibitors , beta-Galactosidase/antagonists & inhibitors , alpha-Galactosidase/antagonists & inhibitors
3.
Indian J Exp Biol ; 1989 Jul; 27(7): 644-6
Article in English | IMSEAR | ID: sea-63324

ABSTRACT

Significant differences were observed in GAG metabolism of S. digitata and one of its intermediate vectors, C. quinquefasciatus. Distribution of different components such as hyaluronic acid, heparin-sulphate, chondroitin-4-sulphate, chondroitin-6-sulphate, dermatan sulphate and heparin was comparable in both. However, there were quantitative differences; the difference was marked in the activity of enzymes of GAG metabolism in presence and absence of diethylcarbamazine (DEC) a known antifilarial drug. While the activities of beta-galactosidase and beta-N-acetyl glucosaminidase of S. digitata systems showed an inhibition of 96.5 and 92.6% respectively, in the Culex systems they showed an inhibition of 93.3% and an activation of 18% respectively. The differences clearly indicate the existence of basic differences in GAG metabolism of vector and parasite.


Subject(s)
Acetylglucosaminidase/antagonists & inhibitors , Animals , Culex/drug effects , Diethylcarbamazine/pharmacology , Female , Filarioidea/drug effects , Galactosidases/metabolism , Glycosaminoglycans/metabolism , Hexosaminidases/metabolism , beta-Galactosidase/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL